Diabetes Day Research Articles

World Diabetes Day 2024

World Diabetes Day (WDD) is the main global awareness campaign dedicated to Diabetes mellitus, held annually on November 14 [1] World Diabetes Day, initiated by the International Diabetes Federation (IDF) and WHO, is a testament to our ongoing commitment to the fight against Diabetes. Each World Diabetes Day focuses on a diabetes-related theme. Type 2 diabetes, a noncommunicable disease rapidly increasing in numbers worldwide, can be prevented. Type 1 diabetes, unfortunately, is not preventable but can be managed with insulin injections[2]. The day also includes discussions on human rights, NCDs and lifestyle, obesity, Diabetes in the LMIC and the vulnerable, and Diabetes in children and adolescents. The campaigns, which run year-round, ensure that we are constantly engaged in the fight against Diabetes, not just on November 14 but every day of the year. The day marks the birthday of Frederick Banting, who, along with Charles Best, first conceived the idea that led to insulin’s discovery in 1922[3]

Global Diabetes Walk Campaign on World Diabetes Day 14th Nov in UP India its impact on Public health Facility policy

It all began in 2004 with a simple idea: by organizing walks on World Diabetes Day, organizations and individuals could raise awareness about diabetes and how to prevent it; these walks would be low-cost, educational, and fun. WDF would help by providing banners, tools, and guidance; since then 5 million participants in the Global Diabetes Walk worldwide has raised awareness, galvanized communities and even, in some cases, changed public policy

Detection of Dysglycemia, a Pre-Risk Factor for Cardiovascular Events, During World Diabetes Day 2018 and 2019 in An Urban Population Sample

Detection of Dysglycemia, a Pre-Risk Factor for Cardiovascular Events, During World Diabetes Day 2018 and 2019 in An Urban Population Sample

History of World AIDS Day

World AIDS day is observed on December 1 each year. World AIDS Day was first observed in 1988, making it one of the earliest international health days. Its primary purpose has been to raise awareness about HIV/AIDS. In the 1980s, when the HIV/AIDS epidemic emerged, there was widespread fear, stigma, and misinformation about the virus. The first World Health Assembly (WHA) met in 1948 at Geneva. Members of the assembly felt people all over the World suffered in World war. Members discussed global health issues, and felt the need of medical facility for everyone, when they are in need. Hence WHA stressed the importance of awareness of good health and wellbeing. To achieve this awareness about global health, all the members of World Health Organization (WHO), should devote 1 day to talk about good health and wellbeing, and also should provide the necessary medical help. Government organizations and non-governmental organizations of all nations joined hands with WHO. WHO decided to observe “World Health Day (WHD)” every year all over the World. The first WHD was observed on April 7 1950.1 Mahatma Gandhi, father of the Nation deeply sympathized towards the leprosy patients in India. On 30th January 1948, Mahatma Gandhi was assassinated, Government of India decided to observe “Martyrs day 30th January 1948” as “Anti-Leprosy Day in India”. Every year, in India January 30th is observed as anti-leprosy day and entire January month, survey of all villages to detect leprosy cases, school health programme and leprosy awareness programme for common man are conducted. In 1954 French journalist Raoul Follereau saw the success of anti-leprosy awareness activities in India, and he wanted WHA to observe last Sunday of January as World Leprosy Day (WLD)”. Since 1954, every year “Last Sunday of every year is observed as World Leprosy Day”. In 1982, 24th March is observed as “World Tuberculosis Day (WTD)”. Dr. Jonathan Mann made WHA to devote one day in a year to know the increasing menace of HIV/AIDS in 1988. WHA decided to observe 1st December as “World Aids Day (WAD)” since 1988. In 1991, November 14th “World Diabetes Day (WDD)” is observed. In 1992, December 3rd “World Disability Day (WDD)” is observed. In 2007, April 25th “World Malaria Day (WMD)” is observed. Keywords WHA, WHO, WHD, WLD, WAD, WTD

Prevalence of Diabetes Mellitus Among Adult Population Within a Southern Nigerian Community

Background: The prevalence of diabetes mellitus (DM) is increasing globally, particularly in low and middle-income countries, driven by factors like rapid population growth, urbanization, obesity, and physical inactivity. In the south-south geopolitical zone of Nigeria, the pooled prevalence is 9.8%. This study focused on assessing the prevalence of DM in the Rumuomasi community in Port Harcourt, Rivers State, Nigeria. Method: 199 persons participated in this cross-sectional study using convenience sampling carried out at an outreach by GoodHeart and Life Support Initiative in November 2023 at the Rumuomasi community in Obio/Akpor Local Government Area, Rivers state, Nigeria as part of the World Diabetes Day. Fasting blood glucose were collected using two validated glucometers (Kiptrack blood glucose monitor) with a timing of 10 seconds and analyzed descriptively. Results: Out of 199 participants (63 males, 136 females), this study found a 6.53% diabetes prevalence (13 individuals), mostly in the 41-60 age group (n=7) and >60 age group (n=5). Despite this, the majority had normal fasting blood glucose. Pre-diabetes was present in 5.53% of the population. Conclusion: The prevalence of DM in this community (6.53%) was lower than the earlier reported of 6.8% in Port Harcourt in 2003 and 9.0% in Ekpoma, Edo State, Nigeria. This could be as a result of increasing diabetic – awareness programmes. Enlightenment campaigns on routine glucose checks, campaigns highlighting the value of a traditional lifestyle, particularly with regard to diet should be carried out more often.

November 14 — World Diabetes Day

Today, there are about half a billion people with diabetes all over the world, and almost a third of them do not even know about their diagnosis. Expressing serious concern about this state of affairs, in 1991 the International Diabetes Federation proposed that November 14 should be considered World Diabetes Day. It was on this day that the Canadian doctor and scientist Frederick Banting, a Nobel laureate, was born. Together with his colleagues, he discovered insulin and gave millions of patients hope for salvation. This initiative was supported by the World Health Organization, and on this day, for almost thirty years, doctors around the world have urged not to remain indifferent and unsympathetic to those suffering from this terrible disease. Since 2007, World Diabetes Day has been observed under the auspices of the United Nations (UN); this day was proclaimed by the UN General Assembly in a special resolution in 2006.

TYPE 2 DIABETES MELLITUS SCREENING: THE SAMPLE OF SİVAS

ABSTRACT
 Objective: The aim of the study is to screen for Type 2 Diabetes Mellitus (DM), to determine the risk of DM and to evaluate the factors affecting it.
 Method: It is a descriptive study. The population of the research consisted of people over the age of 18 living in Sivas who were not diagnosed with diabetes. The sample of the research consisted of individuals over the age of 18 who did not have diabetes and participated in the event, which was organized as part of the 14 November 2022 “World Diabetes Day” event, which continued between 08.00-17.00. In order to reach the universe, a stand was set up in the city center in the square where the people are concentrated. Capillary blood glucose measurement, a questionnaire including height, weight, demographic characteristics and Finnish Diabetes Risk Questionnaire (FINDRISK) were applied to the patients. FINDRISK consists of 8 questions. It determines an individual's risk of developing diabetes in the next ten years. Results are shown as frequencies, mean±standard deviation. Pearson correlation analysis, Student-T test and One way ANOVA test were applied. P

EarLy Surveillance for autoimmune type 1 diabetes - paediatric screening in the UK.

Children with pre-symptomatic type 1 diabetes can be identified through testing for circulating islet autoantibodies. Identifying children at risk reduces the rates of diabetic ketoacidosis at presentation and allows participation in clinical trials for type 1 diabetes prevention. The Early Surveillance for Autoimmune diabetes study (ELSA) is exploring feasibility and acceptability of UK paediatric general population screening. The ELSA study runs from July 2022 to August 2024 and aims to recruit 20 000 children aged 3-13 years. ELSA is screening for islet autoantibodies via dried blood spot (DBS) and subsequent staging via oral glucose tolerance testing. ELSA is exploring feasibility and acceptability of UK paediatric general population screening. At the time of writing, 2582 children have been consented to the study. In the preliminary beta version (July-October 2022), there were 59 expressions of interest, 37 children consented (63%) and 22 kits returned (59%). Of the consented children, 17 families were invited and 8 were passive recruits through friends/family. Reasons for not returning the kit included issue with home-testing (n=1) and concern about the lancet (n=1). One of the DBS kits screened positive (4.5%), but the serum confirmation did not detect autoantibodies. The study launched nationally via social media on 14 November 2022 (World Diabetes Day) leading to a surge in expressions of interest (n=3070). Of these, 2141 children were consented within 36 hours. Social media has been an effective route to recruitment. Community outreach to schools and general practices will be implemented as this study evolves, to explore optimal recruitment modalities and acceptability.

Study of preferences of patients with diabetes regard to pharmaceutical services

Pharmacies are a component of the healthcare. Pharmaceutical care and pharmaceutical services improve disease control, quality of patients life and reduce of the burden on healthcare. The implementation of pharmaceutical care and pharmaceutical services for patients with diabetes according to the standards of the GPP is relevant for the domestic pharmacy. Therefore, it is advisable to determine the preferences of patients with diabetes because they have their own needs for treatment and control.
 The purpose of the study was to study the views of patients with diabetes regarding to function of pharmacies, pharmaceutical services and determine their preferences.
 The survey of patients with diabetes by the questionnaire method was carried out. Relevant questionnaires of 510 patients with type 1 and type 2 diabetes were included in the study.
 The results of the survey showed that the majority of patients with diabetes would like to be served in a specialized pharmacy that specializes in drugs and medical products for diabetes. On the basis of the study, the preferences of patients with diabetes regarding to the activities of pharmacies were determined: availability of a wide rang of product; loyalty program for special products related to diabetes, additional services and pharmaceutical consultations. The majority of those interviewed noted that they need a pharmacist's consultation on taking medications. This type of service requires training of pharmacists in diabetes in order to provide pharmaceutical care at an appropriate level. Pharmaceutical services which patients with diabetes need were identificated. There are: testing of blood glucose, cholesterol, blood pressure, weight check, calculation of body mass index and interpretation of results. The creation of a «diabetes self-management school» based on pharmacies will improve the availability of education for patients with diabetes. It is necessary to study the demand directly in the area of the pharmacy before introduction this type of service. It is important to implement systematic special events in pharmacies for the World Diabetes Day. Thes is appropriated for the general population, but also for patients with diabetes. From the point of view of patients with diabetes during this event, they are interested in: consultation of an endocrinologist and nutritionist; blood glucose test; test of diabetes risk; information materials about diabetes.
 The results of the survey can be prospectively used to improve the service of patients with diabetes and provide for their needs.

In World Diabetes Day, assessment of the chronic diseases among general population in Riyadh, KSA

In World Diabetes Day, assessment of the chronic diseases among general population in Riyadh, KSA

Utilization of Google Trends in Knowing Public Attention to Diabetes in Indonesia in 2018

Diabetes is one of the four non-communicable diseases that are prioritized because of the sufferer’s number and the increasing prevalence rate. The results of the 2018 Basic Health Research shows an iceberg phenomenon where there are far more people living with diabetes who have not been diagnosed than those who live with diabetes and know their condition. The public's desire to find out in advance the disease that may be suffered on Google opens up opportunities of research in public concern about diabetes. This research with descriptive analysis aims to describe the public's attention to diabetes based on Google Trends data. The results show that the development of public attention in 2018 tends to fluctuate with the highest index on World Diabetes Day. Then there are provinces that need attention with high diabetes prevalence values ​​but still have a low volume of diabetes-related searches. Most topics related to diabetes are about the drugs, causes, and symptoms of diabetes. So it is necessary to socialize diabetes literacy, especially in areas with low public attention

Analysis of Hashtag #educationtoprotecttomorrow in Social Media Posts to Increase Self-Health Awareness on World Diabetes Day

Penggunaan hashtag dalam unggahan di media sosial dapat menjadi salah satu upaya untuk meningkatkan kesadaran diri terhadap isu terkini. Dalam beberapa hal, penggunaan hashtag masih disalahgunakan. Penelitian ini bertujuan untuk menganalisis kualitas penggunaan hashtag #educationtoprotecttomorrow ditinjau dari aspek tipe, sumber, kredibilitas, bahasa, tujuan, popularitas, dan autentifikasi unggahan. Penelitian cross-sectional terhadap 200 unggahan di Instagram dan Facebook yang menggunakan #educationtoprotecttomorrow. Mayoritas unggahan baik di Instagram dan Facebook adalah berjenis gambar, penggunggah adalah organisasi, kredibilitas unggahan benar, menggunakan Bahasa inggris, bertujuan edukasi, mendapat likes < 50, dan penggunggah belum terautentifikasi. terdapat hubungan yang signifikan antara jenis sosial media terhadap jenis unggahan (p=0,02) dan kredibilitas unggahan (p=0,00). Kualitas dan jangkauan unggahan dapat ditingkatkan dengan partisipasi berbagai pihak khususnya dengan penggunaan gambar serta menyajikan informasi yang kredibel. Keterlibatan pemerintah dan organisasi yang berisi tenaga kesehatan dapat membantu meningkatkan kredibilitas informasi yang disajikan.

Virtual Delivery of World Diabetes Day During COVID-19: Lessons Learned from the Field

ABSTRACT Background Following the spread of COVID-19, the Rhode Island Department of Health delivered its first virtual World Diabetes Day (RIWDD) event. Evaluations exploring advantages and disadvantages of delivering public health events virtually are generally lacking. Purpose The aims of the present paper were to evaluate the reach, feasibility, and effectiveness of delivering RIWDD virtually. Methods Quantitative methods were used to: (1) estimate and compare the target population to RIWDD’s event reach; and (2) evaluate whether diabetes knowledge increased amongst attendees. Qualitative methods assessed event facilitators’ perceptions of the strengths, limitations, and challenges of using a virtual format to inform planning and implementation of future RIWDD events. Results Results revealed segments of RI’s population disproportionately affected by diabetes, including men, persons of color, and older adults were underrepresented at the event. The event was not associated with increases in diabetes knowledge; however, attendees possessed high diabetes knowledge overall. Facilitators identified several important factors associated with virtual delivery in the context of COVID-19. Discussion Considerations for delivering virtual events are discussed. Translation to Health Education Practice A key takeaway of this evaluation is the critical need for cultural competency as a guiding framework for professional practice when delivering events virtually.

November 14 — World Diabetes Day

Today, there are about half a billion diabetic patients worldwide, and almost a third of them do not even know about their diagnosis. Expressing serious concern about this state of affairs, in 1991 the International Diabetes Federation proposed November 14 to be designated as World Diabetes Day. It was on this day that the Canadian doctor, scientist and a Nobel laureate Frederick Banting was born. Together with his colleagues, he discovered insulin and gave millions of patients hope for salvation. This initiative was supported by the World Health Organization, and for almost thirty years now, doctors around the world have been calling not to remain indifferent on this day to patients with this terrible disease. Since 2007, World Diabetes Day has been held under the auspices of the United Nations (UN); this day was proclaimed by the UN General Assembly in a special resolution in 2006.

IDF21-0555 Diabetes mellitus: The silent epidemic overrunning developing countries

Background: A fast growing epidemic of diabetes is occurring in many countries. The most dramatic increase has been in low- and middle-income countries, including Tunisia. This pandemic remains hidden in most of the world, which makes it particularly dangerous. Aim: The objectives of our study were to: * Carry out the precocious diagnosis of diabetes in subjects who volunteer for the screening campaign. * Calculate the prevalence of this pathology in the screened population. * Determine the associated epidemiological factors of this pathology. Method: This is a regional descriptive cross-sectional study that has been investigated through a survey to the city of a representative sample of the Tunisian population in order to assess, through questionnaires, its health status, and medical consumption, during the World Day of Diabetes screening during the years 2014 and 2015. The screening involved 2012 individuals 18 years of age and older. During the study, blood glucose measurement was based on fingertip blood glucose monitoring with ON-CALL® and BIONIME® blood glucose monitors. Results: The median age was 52 years with extremes ranging from 19 to 85 years. The majority of patients were between 51 and 60 years of age (31.5%). Our study noted a male predominance with a sex ratio of 2.1. Among the subjects screened, 27.5% were smokers and 10.9% were alcoholics. A family history of diabetes and hypertension was found respectively in 47.37% and 48.56% of the screened subjects. Fasting blood glucose (FBG) was performed in only 8.7% of screened subjects, and postprandial blood glucose (PPG) in 71.3% of screened subjects. In our study, 20% had known diabetes, 3% had unrecognized diabetes and 9.9% had undiagnosed prediabetes. The remaining part of the screened population (67.1%) did not present any abnormalities of glucose metabolism within the limits of the means of exploration used. Almost half of all people with diabetes have unmanaged diabetes. Discussion: Screening campaigns, especially those conducted on World Diabetes Day, remain the most effective strategy to raise awareness of the progression of diabetes, its tremendous impact, and its consequences, especially in low and middle-income countries.

CELEBRATING 100 YEARS OF INSULIN USE.

The year 2022 marked the one-hundredth anniversary of the first application of insulin. November 14th, the birth date of one of its main discoverers, Frederick Banting, was designated as World Diabetes Day. This paper comprises a narrative review of the history of the discovery of diabetes and insulin, progress in insulin development, important breakthroughs in insulin production and delivery, and a short commentary regarding potential future developments in insulin treatment. Diabetes, as one of the earliest recorded illnesses in medical writings, has been a focus of research for almost the entire written human history. Groundbreaking discoveries during the early 20th century have resulted in type 1 diabetes mellitus becoming a treatable, chronic condition. The relationship between good glycemic control and reduced occurrence of diabetes complications was established, which has enticed further development and refinements in insulin treatment, ranging from the purification and increased quality of insulin itself, as well as various inventions in its administration. Despite great achievements in insulin therapy so far, future research aims to avoid the need for subcutaneous administration and to create non-invasive means of insulin application.

Improving access to diabetes care in Nigeria – The GIFSHIP opening

Diabetes mellitus, has continued on a relentless upward trajectory globally, with profound socio-economic consequences. Not surprisingly, the International Diabetes Federation in collaboration with the World Health Organization and the United Nations; in commemoration of the World Diabetes Day 2021, aptly chose the theme – ‘Access to Diabetes Care - If Not Now, When?’ for the year 2021 (the centenary anniversary of insulin discovery), till 2023; to underscore the difference which having access to diabetes care can make, in relation to diabetes management. The Group, Individual and Family Social Health Insurance Program (GIFSHIP) is a non-formal sector insurance package for individuals; groups; and family units in Nigeria, recently introduced by the federal government, to improve universal health coverage.The inherent positive contributions of the GIFSHIP, towards improving access to diabetes care in Nigeria was reviewed.MEDLINE, Omni and Google Scholar searches were conducted using keywords - access to diabetes care, barriers to diabetes care, GIFSHIP, and Nigeria. Relevant studies were extracted and reviewed. Authors summarized health care access, narrowing down to diabetes care access. The opportunity for improved access to diabetes care, which the GIFSHIP presents was highlighted. The role of the Diabetes Association of Nigeria (DAN) in advancing the uptake of, and utilization of the GIFSHIP package for their members, was explored.The GIFSHIP showed great promise for improving access to diabetes care in Nigeria, while the DAN was projected as an effective channel for dissemination and uptake of the GIFSHIP among individuals with diabetes.

A cien años de la concepción de una idea: insulina y diabetes

We have witnessed the change in life that was imposed with the passage of COVID throughout the world, now we will have the opportunity to carry out an intimate account of what we have learned during the last twelve months and not stop taking care of who we are and what we still have . The World Health Organization established November 14, the day of the birth of Frederick Banting, considered the father of insulin, as World Diabetes Day, with the desire to raise awareness about the dangers of this deadly disease to which we continue to give battle without quarter This 2022 will be the 100th anniversary of the first diabetic patient treated with insulin, a date that should not be forgotten. Since the application of this first dose of insulin to Leonard Thompson, much progress has been made in relation to the treatment of patients with Diabetes Mellitus.

Assessing diabetes mellitus knowledge among Syrian medical students: A cross-sectional study

BackgroundDiabetes mellitus is the fastest growing global health emergency of the 21st century. The Middle East and North Africa region have the highest prevalence of diabetes in the world. Since medical students are the pillars of future healthcare systems, their knowledge of the disease must be evaluated, updated, and enhanced appropriately. MethodsA cross-sectional study was conducted at the Syrian Private University (SPU) in November 2019 on World Diabetes Day in Damascus, during the Syrian war crisis. Data were collected through self-administered questionnaires and analyzed using the Statistical Package for Social Sciences version 25.0 (SPSS Inc., United States). ResultsOf the 275 students, 74 (26.9%) were preclinical students and 201 (73%) were clinical students with a mean age of 21.9 (±3.70) years. 67 (25.0%) are overweight, and 26 (9.7%) are obese. Students revealed a good level of knowledge regarding clinical features, risk factors, and complications; however, a lack of knowledge was noticed in the general information and the diagnostic criteria section. Clinical year students (4th, 5th, 6th) demonstrated higher levels of awareness compared to students in pre-clinical years (1st, 2nd, 3rd). ConclusionsKnowledge and awareness of medical students about diabetes mellitus were found to have some gaps. Health education efforts are required to reinforce its identification and management at all levels, while also encouraging lifestyle modifications among our students.

COVID año 1. Día Mundial de la Diabetes

On the occasion of the celebration of World Diabetes Day (WDD) in 2020, users who have come to the Pharmacy have been given a determination of capillary glucose. Compared to the similar determination made by the same WDD in 2019 at the same Pharmacy, the values found have been compared with a different sample. In 2020, a total of 127 people were recruited compared to 54 in 2019. Median glucose has not changed significantly from year to year or in total patients (105 mg/dL in 2020 vs 105.5 mg/dL in 2019;p=0.53) neither in the subgroups of those taking antidiabetic medication (157 mg/dL in 2020 vs 187 mg/dL in 2019;p=0.16) or in those who do not take (103 mg/dl in 2020 vs 99 mg/dL in 2019;p=0.21). This non-observation of changes makes us reflect on how to detect future glucose control alternations, especially in diabetic patients. To do this, it will be necessary to use more robust estimators, such as glycosylated hemoglobin and work with stable groups of patients.